Andrew V. Schally, Ph.D., M.D.(hc), D.Sc.

Roles

• Biography

  + –
  Dr. Schally was the corecipient of the Nobel Prize in Physiology or Medicine in 1977. His work has defined the role of the hypothalamus and human growth hormone as well as understanding and developing treatments for hormone dependent cancer. He has received more than thirty honorary degrees as well the award of Chevalier of the Legion d’honneur from France.

• Education & Training

  + –

  Education

  1957: McGill University, Montreal, Canada

  PhD

• Research Interests

  + –
  Development and evaluation of peptide analogs with antitumor activity including targeted cytotoxic analogs of LHRH, somatostatin and bombesin and antagonistic analogs of GHRH Inhibitory effects of peptide analogs on various cancers, including prostate cancer, pancreatic cancer, gastric cancer, colon cancer, malignant brain tumors, lung cancer (SCLC and non-SCLC), renal cancer and osteosarcomas, melanomas, hepatocellular carcinoma and lymphomas as well as breast cancers, ovarian cancers and endometrial cancers. Mechanism of action of GHRH antagonists and its receptors. Mechanism of action of LHRH antagonist Cetrorelix on BPH. Evaluation of hypothalamic peptide analogs in cardiology, diabetic nephropathy and Alzheimer's disease.

• Publications

  + –
  Disclaimer: The information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, please use this link to inform our data team. Your feedback is greatly appreciated and helps us improve the quality of our content.

  
  

  See all Publications